Race, obesity, and risk for prostate cancer

By using data from the prospective SELECT trial (the Selenium and Vitamin E Cancer Prevention Trial, conducted between 2001 and 2011), researchers have been able to suggest that obesity is strongly associated with increased risk for prostate cancer diagnosis among African American males compared to non-Hispanic whites. … READ MORE …

Mortality, body mass index, and Gleason score: the relationship

New data appear to suggest that you really don’t want to be diagnosed with high-risk prostate cancer if you are significantly over-weight or obese. … READ MORE …

BMI correlates to risk for biochemical recurrence post-surgery

According to data presented on Tuesday at the American Association for Cancer Research annual meeting in Chicago, body mass index (BMI)  at the time of surgery correlates with risk for biochemical recurrence of prostate cancer after first-line treatment with radical prostatectomy. … READ MORE …

Thursday news update, Part B: October 30, 2008

Part B of today’s prostate cancer news update includes information about:

  • Screening behaviors of Afro-Caribbean men in Brooklyn, NY
  • Weight loss and prostate cancer risk
  • Potential of upgrading and upstaging of men with “favorable” prostate cancer on diagnosis
  • Effects of ADT on body lean and body fat mass
  • Salvage radiotherapy + androgen deprivation and toxic impact of treatment … READ MORE …

Tuesday’s prostate cancer news: October 14, 2008

In today’s update there is information about:

  • Excess body mass and risk from prostate cancer death
  • The potential role of the PCA3 test
  • Focal treatment for localized disease using targeted photodynamic therapy … READ MORE …